Difference between revisions of "Azilsartan"

From Self-sufficiency
Jump to: navigation, search
(updates)
 
m (1 revision)
 
(No difference)

Latest revision as of 15:44, 19 September 2010

Azilsartan
File:Azilsartan medoxomil.svg
Systematic (IUPAC) name
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-([2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl)-1H-benzimidazole-7-carboxylate
Identifiers
CAS Number 863031-21-4
ATC code none
Chemical data
Formula C30H24N4O8
Molar mass 568.5[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Azilsartan (INN) is an angiotensin II receptor antagonist undergoing research for the treatment of hypertension.

As the prodrug azilsartan medoxomil (INN, codenamed TAK-491), it was developed by Takeda. As of 2010, phase III clinical trials have been completed, and the drug is under review by the U.S. Food and Drug Administration.[1][2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


Antihypertensives: agents acting on the renin-angiotensin system (C09)
ACE inhibitors
("-pril")
AIIRAs/
("-sartan")
Azilsartan† • Candesartan • Eprosartan • Irbesartan • Losartan • Olmesartan • Tasosartan§ • Telmisartan • Valsartan
Renin inhibitors/
("-kiren")


30px This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it.
pt:Azilsartan
  1. ↑ "Complete list of clinical trials for azilsartan (ClinicalTrials.gov)". Retrieved 2008-06-20. 
  2. ↑ Collins TR (2010-08-02). "New ARB shows good results in blacks". Medscape. Retrieved 2010-08-02. 
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Azilsartan&oldid=22383"